Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Camila Boniche-Alfaro"'
Autor:
Kasturi Banerjee, Michael P. Motley, Camila Boniche-Alfaro, Somanon Bhattacharya, Raj Shah, Andrew Ardizzone, Bettina C. Fries
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 4 (2022)
ABSTRACT The most pressing challenge for the development of anti-capsular antibodies is maximizing coverage against the heterogenous capsular polysaccharide (CPS) of carbapenem-resistant Klebsiella pneumoniae (CR-Kp). So far, only CR-Kp with wzi154 C
Externí odkaz:
https://doaj.org/article/2f5969ee3e46430eb522014b2f613fdf
Autor:
Brenda Kischkel, Camila Boniche-Alfaro, Isabela de Godoy Menezes, Suelen Andreia Rossi, Claudia Blanes Angeli, Sandro Rogério de Almeida, Giuseppe Palmisano, Leila Lopes-Bezerra, Joshua D. Nosanchuk, Carlos Pelleschi Taborda
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
As there are more than 6 million human deaths due to mycoses each year, there is an urgent need to develop fungal vaccines. Moreover, given the similarities among pathogenic fungi, it may be possible to create a multi-fungi vaccine. In this study, we
Externí odkaz:
https://doaj.org/article/2fd4aaf9f76b48d4a04e8d5b14f7f9c2
Autor:
Camila Boniche-Alfaro, Brenda Kischkel, Luciana Thomaz, Monique Maria Carvalho-Gomes, Leila M. Lopes-Bezerra, Joshua Daniel Nosanchuk, Carlos Pelleschi Taborda
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Monoclonal antibodies (mAbs) are promising alternatives to treat infectious diseases, especially given their potential for applications in combination therapies with antimicrobial drugs to enhance the antifungal efficacy. Protection mediated by mAbs
Externí odkaz:
https://doaj.org/article/0cc2c2a4288d4487bf0301286c108226
Autor:
Kasturi Banerjee, Michael P. Motley, Camila Boniche-Alfaro, Somanon Bhattacharya, Raj Shah, Andrew Ardizzone, Bettina C. Fries
Publikováno v:
Microbiology Spectrum. 10
Here, we presentin vitroandin vivodata for thewzi50CPS-specific monoclonal antibody MAb 24D11, demonstrating its cross-protective efficacy against three prominentwintypes (wzi29,wzi154, andwzi50) of the carbapenem-resistant clonal group CG258. In a m